Jubilant Pharmova Limited has informed the Exchange about Copy of Newspaper Publication
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jubilant Pharmova has submitted to the stock exchanges copies of newspaper publications carrying its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26). The results were published in Financial Express (English) and Hindustan (Hindi) on July 30, 2025, and included a Quick Response Code along with the webpage link where investors can access the full results. The Board of Directors had approved these results at its meeting held on July 29, 2025. The filing has been made under SEBI Listing Regulations to comply with disclosure requirements.
This is a routine regulatory compliance filing confirming that the Q1 FY26 results, already announced on July 29, have been published in newspapers as required. No new financial information is being disclosed here, so the impact on shareholders or the stock price is neutral.